Shon Green

Co-Founder Zelig Tx

Shon is Co-Founder and CSO of Zelig Therapeutics, an in vivo cell therapy company developing next-generation immune engineering approaches for severe allergic disease. She previously held senior leadership roles at Umoja Biopharma, where she helped pioneer in vivo CAR-T technologies, and at Adice Bio, where she advanced allogeneic CAR-T programs for solid tumors and autoimmune disease into the clinic.

Shon Green - Zelig Therapeutics - Expert Speaker at the 11th CAR-TCR Summit 2026